| Name | Title | Contact Details |
|---|
Computer and Allied Technology Solutions is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bare Necessities Laser Colorado is a Littleton, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 1955 and located on a 30-acre campus in Sellersville, Pennsylvania, Penn Foundation is a not-for-profit organization providing innovative services that address the mental health, substance use, and intellectual disability needs of our community. Through a broad range of diverse programs that can be tailored to meet individual needs, Penn Foundation provides compassionate, responsive care to more than 10,000 children, adolescents, and adults each year. Our tradition of compassionate care combined with a strong belief in the healing power of hope and the possibility of recovery enables us to help individuals and families grow, develop, and recover to their fullest mental, emotional, and spiritual health.
InnovAge helps seniors age in their own homes with dignity through the Program of All-inclusive Care for the Elderly (PACE). InnovAge is dedicated to expanding this successful program to serve as many seniors as possible across the country. We hire exceptional people for our programs in California, Colorado, New Mexico, Pennsylvania, and Virginia. Our mission is to sustain and enhance the independence and quality of life for those we serve, on their terms. Our purpose is to help older adults remain mobile, prolong their health, and continue living in their own homes.
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.